Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin for Liver Fibrosis in HIV/HCV
NCT01654939Phase 4Withdrawn
- Start
- Oct 2012
- Primary completion
- Sep 2014
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of rifaximin in Liver Fibrosis (LF). Planned start Oct 2012; status: withdrawn.
02
Drugs
rifaximin
03
Conditions
Liver Fibrosis (LF)
Beyond the preview
Go deeper on NCT01654939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01654939.